← k3vl4r
Log inGet started →

QGEN (Qiagen) Price Forecast

AI-generated price forecast for Qiagen (QGEN) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads QGEN as split 1/1 across its horizons (1 of 2 timeframes pointing up), with a last price of 44.75. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status📊 Full AI report· ACCUMULATE

Last price

44.75

AI outlook

split 1/1

Timeframes up

1 / 2

Share𝕏PostTelegram

QGEN forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▼ Down-1.55%100%
Weekly~1.8 years out▲ Up+13.77%—

Latest QGEN news

From the market-news feed the forecasts are read against.

  • Qiagen (QGEN), What Is Behind The Fresh Attention Now? · Simply Wall St. · Sep 28
  • What Qiagen (QGEN)'s Expanded Sepsis Testing Portfolio Means For Shareholders · Yahoo · Sep 28
  • QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel · Yahoo · Sep 28
  • FDA Clears QIAGEN's Gram-Negative QIAstat-Dx Bloodstream Panel, Joining Gram-Positive And Fungal Panel To Cover 33 Pathogen Targets And 28 Resistance Marker · Benzinga · Sep 27
  • QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation · Yahoo · Sep 24

🔒

See the full QGEN forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

QGEN forecast — frequently asked

Will QGEN go up?

K3vl4r's AI model currently reads QGEN as split 1/1 — 1 of 2 forecast horizons point up, so the overall read is mixed. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the QGEN price prediction for 2026?

K3vl4r's model projects QGEN toward $44.88 over the next ~3 months, a -0.0% move from $44.88. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could QGEN reach?

Over its longest horizon (~~1.8 years), the model's projected target for QGEN is $42.10 (+0.1% vs $42.04). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

MTDTMOABTDHRTECHHCACHEMCKENSGLHWATILMNCVSDGX

Will QGEN reach…?

Will QGEN reach $50.00?Will QGEN reach $100.00?Will QGEN reach $200.00?Will QGEN reach $250.00?

Or see the full QGEN price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare QGEN

QGEN vs MTDQGEN vs TMOQGEN vs ABTQGEN vs DHRQGEN vs TECHQGEN vs HCA

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.